Therefore, by substituting for niacin and activating upregulated HCAR2, βHB may be able to target a set of sensitized pathways in the PD brain, pathways that include the critical proteins SIRT1 and NFκB (Figure 4). Here, NFKB1 is linked to Parkinson disease.